Bipolar Disorder  >>  Vraylar (cariprazine) 
Welcome,         Profile    Billing    Logout  

8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie
2021-006706-69: Lithium versus cariprazine in the treatment of bipolar depression

Not yet recruiting
4
122
Europe
Cariprazine, lithium citrate, Capsule, hard, Tablet, Reagila, Litarex
Psychiatry – Aalborg University Hospital, Unit for Psychiatric Research, Danske Regioner, Region Nordjylland
Bipolar disorder, current depressive episode. -Bipolar affektiv lidelse, aktuel depressiv episode, Patients with a diagnoses of bipolar disorder who have a depressive episode, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
DUAG9, NCT05913947: Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression

Recruiting
4
122
Europe
Lithium, Litarex, ATC; N05AN01, Cariprazine, Reagila, ATC: N05AX15
Aalborg University Hospital, Mental Health Center, Glostrup, Mental Health Center North Zealand, Mental Health Department Odense, University Clinic, Psychiatric Center Copenhagen, Rigshospitalet
Depression, Bipolar
09/24
09/24
SMART-BD, NCT06433635: Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Not yet recruiting
4
2726
Canada, US
Cariprazine, Vraylar, Aripiprazole/Escitalopram combination, Abilify/ Lexapro, Quetiapine, Seroquel, Lurasidone, Latuda
Massachusetts General Hospital, Patient-Centered Outcomes Research Institute
Bipolar I Disorder, Depression
02/30
02/30
NCT05060549: Dopamine D3 Receptor Occupancy in Bipolar Depression

Not yet recruiting
4
8
US
Cariprazine, Vraylar
New York State Psychiatric Institute
Bipolar Depression
10/25
10/25
NCT04777357: A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting
3
380
US, RoW
Cariprazine, Vraylar, Placebo
AbbVie
Depression, Bipolar I Disorder
03/27
03/27
NCT04578756: Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Recruiting
3
325
US
Cariprazine Flexible Dose
AbbVie
Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD)
09/25
09/25
CARPZ-01, NCT04771299: Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients

Recruiting
3
30
Canada
Cariprazine, VRAYLAR®, Placebo
Jayasree Basivireddy
Bipolar I Disorder, Cognitive Impairment
09/25
09/26
CReW BP-I, NCT06256367: Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder

Recruiting
N/A
170
Canada, US
AbbVie
Bipolar I Disorder
07/25
07/25

Download Options